SLC16A1 helps make a transport protein that moves lactate and ketones, small molecules your body uses for energy, across cell membranes. Your cells depend on this gene when they need to shift fuel during exercise, fasting, and other times of stress. If the SLC16A1 gene does not work properly, some people can have problems with energy balance, including repeated episodes of too many ketones in the blood or low blood sugar triggered by exercise, depending on the variant. This gene is mainly known in medicine rather than popular culture.
What is a gene?
A gene is a stretch of DNA that carries information your cells use to make molecules or regulate processes in the body. Some genes hold the instructions for producing proteins, the parts of cells that do the work. Other genes mainly control when certain processes happen, where they happen, and how strongly they run. As a group, genes influence how the body develops and works, and they can also shape how you respond to food, stress, or medications. To go into this topic in more detail, you can find more in the LearnHub.
Overview
SLC16A1Gene function
What if the gene works
The SLC16A1 gene helps move lactate, pyruvate, and ketones into and out of cells. This supports energy use, especially in muscle, the heart, and red blood cells.
Risk
What if the gene does not work
More disruptive variants in the SLC16A1 gene can lead to repeated ketoacidosis, especially during illness or fasting. Other variants can cause low blood sugar during exercise from excess insulin, and effects may range from mild to more pronounced.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently guided specifically by a pathogenic or loss-of-function variant in the SLC16A1 gene. The SLC16A1 gene is being studied as a drug target in some cancers, where blocking its lactate transporter may help slow tumor growth.
Conditions associated with SLC16A1
Gene function
What if the gene works
The SLC16A1 gene helps cells move lactate and other small fuel molecules across the cell surface. This steady traffic supports how muscles, the heart, and many other tissues make and share energy from moment to moment. It also helps cells manage acidity during normal activity and exercise.
This core SLC16A1 gene function lets cells move lactate in and out through the cell membrane. It lets tissues release lactate when they make it and take it up when they can use it as fuel.
Some tissues can use lactate as an energy source instead of leaving it unused. By moving lactate between cells, the SLC16A1 gene supports the body’s normal fuel sharing during rest and exercise.
Its protein also transports pyruvate and ketone bodies, small energy carrying molecules the body can use as fuel. This gives cells flexible access to fuel when energy needs change.
SLC16A1 moves these fuel molecules together with a hydrogen ion, a tiny charged particle linked to acidity. This helps cells keep their internal environment more balanced during everyday activity.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. Variants are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more markedly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many SLC16A1 gene variants change how the MCT1 transporter folds, reaches the cell surface, or moves lactate, pyruvate, and ketone bodies. Milder variants may leave some transport activity, while more severe variants can greatly reduce transport or keep the protein from working at the membrane. A different group of variants, often in DNA regions that control gene activity, can switch the SLC16A1 gene on too strongly in certain cells rather than weaken it.
How variants are linked to conditions
Pathogenic variants in the SLC16A1 gene are best known for causing exercise-induced hyperinsulinemic hypoglycemia, a rare condition in which physical activity can trigger low blood sugar. This makes the SLC16A1 gene exercise-induced hypoglycemia link the clearest and most established clinical association. Some other SLC16A1 variants have also been linked to monocarboxylate transporter 1 deficiency, which may include repeated ketoacidosis episodes and related symptoms.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are widely seen across the general population. Most do not directly affect health and instead reflect normal human variation. For many genes, having a variant connected with a condition points to a possible association, not a certain diagnosis, particularly when several genes and environmental influences also play a part. There are cases, though, where one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For some people with certain SLC16A1 changes, hard or sudden exercise can trigger symptoms, especially low blood sugar episodes. Long gaps without eating may also make episodes more likely. Risk can vary by the exact gene change, so day-to-day triggers are often more important than general lifestyle risk factors.
Inheritance of SLC16A1 variants
The inheritance pattern for SLC16A1-related conditions can differ depending on the specific condition and variant type. In families with exercise-induced hyperinsulinism, SLC16A1 variants are inherited in an autosomal dominant pattern, so a parent carrying the variant can pass it to each child with a 50% chance. Other SLC16A1-related conditions have been reported with autosomal recessive inheritance, which means a child usually inherits one altered copy from each parent. This is the key point in how SLC16A1 variants are inherited. Because the SLC16A1 gene is on chromosome 1, an autosome, copies of the gene are inherited from both parents.
What does my SLC16A1 result mean for my family?
For SLC16A1, the best-known inherited condition is usually passed down in a dominant way, so close relatives such as a parent, brother, sister, or child may also carry the same gene change. In families with this kind of result, some relatives may have episodes of low blood sugar, especially with exercise, while others may have milder signs. The meaning for family members depends on the exact SLC16A1 change and the condition linked to it.
Genetic information
Genetic testing
How you find out about variants
SLC16A1 genetic testing uses a blood or saliva sample to read the SLC16A1 gene and look for variants. In the lab, your DNA sequence is compared with the usual reference sequence to spot changes. Results may show a relevant variant, no meaningful change, or a variant of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the SLC16A1 gene may be worth considering if someone has repeated episodes of low blood sugar during or after exercise, especially if this runs in the family. A result can help confirm an inherited cause and may help relatives understand their own risk.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, yet how much it explains depends on the condition and on the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. One person may break down a drug more slowly, move it into cells differently, or be more sensitive to its effects, while another person taking the same treatment may notice less benefit or more side effects. These differences are common and help explain why medication response is not the same for everyone.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences affect a person’s response to medications. By looking at links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can support more informed, more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the SLC16A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices or routine treatment decisions. Questions about side effects, changes after starting a medicine, or other health concerns are best discussed with your doctor.